By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — There’s potentially exciting news from a trial ...

Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The Trump administration is appealing the court order to reinstate grants and says it will fight “divisive DEI” in science.

Data from Russia’s defence ministry shows HIV rates among enlisted personnel have skyrocketed since the outbreak of the ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.